Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis

BACKGROUND: Being protease inhibitors and owing to their efficacy in SARS-CoV, lopinavir + ritonavir (L/R) combination is being used in the management of COVID-19. In this systematic review and meta-analysis, we have evaluated the comparative safety and efficacy of L/R combination. MATERIALS AND MET...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Indian J Pharmacol
Główni autorzy: Bhattacharyya, Anusuya, Kumar, Subodh, Sarma, Phulen, Kaur, Hardeep, Prajapat, Manisha, Shekhar, Nishant, Bansal, Seema, Avti, Pramod, Hazarika, Mythili, Sharma, Saurabh, Mahendru, Dhruv, Prakash, Ajay, Medhi, Bikash
Format: Artigo
Język:Inglês
Wydane: Wolters Kluwer - Medknow 2020
Hasła przedmiotowe:
Systematic Review and Meta-Analysis (Original Article)
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7722914/
https://ncbi.nlm.nih.gov/pubmed/33078733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijp.IJP_627_20
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy